Literature DB >> 15562130

Ownership and use of tissue specimens for research.

Rina Hakimian1, David Korn.   

Abstract

Academic and industrial scientists have sharply increased their demand for properly prepared and clinically annotated tissue samples that yield valuable insights into the origins and expressions of human disease. Historically, research on human tissue samples has been relatively unencumbered by federal regulations and occurred without delineation of ownership rights to the specimens, patient data, or research products. As regulations have become increasingly restrictive, and because clear ownership interests have never been established, the presumed right of researchers and institutions to collect, use, and dispose of specimens and their associated patient data has remained undefined and occasionally contentious. Recent examination of these issues by a US federal court resulted in a ruling that individuals do not retain rights of ownership or control of biological materials contributed for research, regardless of whether commercial benefit accrues. This article examines the legal, regulatory, and ethical framework within which human tissue research is currently conducted. We contend that because the benefits of medical knowledge derived from tissue research potentially accrue to all individuals and future generations (rather than a single recipient), society may justify an expansive use of these valuable resources for future studies.

Entities:  

Keywords:  Biomedical and Behavioral Research; Legal Approach; Moore v. Regents of the University of California

Mesh:

Year:  2004        PMID: 15562130     DOI: 10.1001/jama.292.20.2500

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  16 in total

Review 1.  Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research.

Authors:  R William G Watson; Elaine W Kay; David Smith
Journal:  Nat Rev Cancer       Date:  2010-08-12       Impact factor: 60.716

2.  Defining diagnostic tissue in the era of personalized medicine.

Authors:  Carol C Cheung; Bella R Martin; Sylvia L Asa
Journal:  CMAJ       Date:  2012-07-23       Impact factor: 8.262

3.  Use of human specimens in research: the evolving United States regulatory, policy, and scientific landscape.

Authors:  Marianna J Bledsoe; William E Grizzle
Journal:  Diagn Histopathol (Oxf)       Date:  2013-09

4.  Rethinking clinical delivery of adult stem cell therapies.

Authors:  Nuala Trainor; Alexis Pietak; Tim Smith
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

Review 5.  Ethical and legal issues in research involving human subjects: do you want a piece of me?

Authors:  M B Kapp
Journal:  J Clin Pathol       Date:  2006-04       Impact factor: 3.411

6.  Consenting postpartum women for use of routinely collected biospecimens and/or future biospecimen collection.

Authors:  Claudia A Kozinetz; Kathryn Royse; Sarah C Graham; Xiaoying Yu; Jack Moye; Beatrice J Selwyn; Michele R Forman; Chantal Caviness
Journal:  J Community Genet       Date:  2016-02-11

7.  Lessons that newborn screening in the USA can teach us about biobanking and large-scale genetic studies.

Authors:  Beth A Tarini; John D Lantos
Journal:  Per Med       Date:  2013-01-01       Impact factor: 2.512

8.  Patient perspectives on compensation for biospecimen donation.

Authors:  Samuel C Allen; Minisha Lohani; Kristopher A Hendershot; Travis R Deal; Taylor White; Margie D Dixon; Rebecca D Pentz
Journal:  AJOB Empir Bioeth       Date:  2018-04-26

Review 9.  Brain tumor biobanking in the precision medicine era: building a high-quality resource for translational research in neuro-oncology.

Authors:  Quinn T Ostrom; Karen Devine; Jordonna Fulop; Yingli Wolinsky; Peter Liao; Lindsay Stetson; Marta Couce; Andrew E Sloan; Jill S Barnholtz-Sloan
Journal:  Neurooncol Pract       Date:  2016-12-30

10.  Interstitial Cajal-like cells in human gallbladder.

Authors:  Mihail E Hinescu; Carmen Ardeleanu; Mihaela Gherghiceanu; Laurentziu M Popescu
Journal:  J Mol Histol       Date:  2007-05-31       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.